Filtros de búsqueda

Lista de obras de

A prediction model for sudden cardiac death in patients with heart failure and preserved ejection fraction

artículo científico publicado en 2014

Assessment of long-term effects of irbesartan on heart failure with preserved ejection fraction as measured by the minnesota living with heart failure questionnaire in the irbesartan in heart failure with preserved systolic function (I-PRESERVE) tri

artículo científico

Baseline plasma NT-proBNP and clinical characteristics: results from the irbesartan in heart failure with preserved ejection fraction trial

artículo científico publicado en 2009

Characterization of health-related quality of life in heart failure patients with preserved versus low ejection fraction in CHARM.

artículo científico publicado en 2006

Clinical and Echocardiographic Characteristics and Cardiovascular Outcomes According to Diabetes Status in Patients With Heart Failure and Preserved Ejection Fraction: A Report From the I-Preserve Trial (Irbesartan in Heart Failure With Preserved Ej

artículo científico

Comparison of outcomes after hospitalization for worsening heart failure, myocardial infarction, and stroke in patients with heart failure and reduced and preserved ejection fraction

artículo científico publicado en 2014

Factors Associated With Outcome in Heart Failure With Preserved Ejection Fraction

article

History of atrial fibrillation as a risk factor in patients with heart failure and preserved ejection fraction

artículo científico

Impact of candesartan on nonfatal myocardial infarction and cardiovascular death in patients with heart failure

artículo científico publicado en 2005

International geographic variation in event rates in trials of heart failure with preserved and reduced ejection fraction

artículo científico publicado en 2014

Irbesartan in patients with heart failure and preserved ejection fraction

artículo científico publicado en 2008

Mode of death in patients with heart failure and a preserved ejection fraction: results from the Irbesartan in Heart Failure With Preserved Ejection Fraction Study (I-Preserve) trial

artículo científico publicado en 2010

Mortality and morbidity reduction with Candesartan in patients with chronic heart failure and left ventricular systolic dysfunction: results of the CHARM low-left ventricular ejection fraction trials

artículo científico publicado en 2004

Patient perception of the effect of treatment with candesartan in heart failure. Results of the candesartan in heart failure: assessment of reduction in mortality and morbidity (CHARM) programme

artículo científico publicado en 2005

Practical recommendations for the use of ACE inhibitors, beta-blockers, aldosterone antagonists and angiotensin receptor blockers in heart failure: putting guidelines into practice

artículo científico publicado en 2005

Prognostic Value of Insulin-Like Growth Factor-Binding Protein 7 in Patients with Heart Failure and Preserved Ejection Fraction

artículo científico publicado en 2016

Prognostic value of baseline plasma amino-terminal pro-brain natriuretic peptide and its interactions with irbesartan treatment effects in patients with heart failure and preserved ejection fraction: findings from the I-PRESERVE trial

artículo científico

Relation of peripheral collagen markers to death and hospitalization in patients with heart failure and preserved ejection fraction: results of the I-PRESERVE collagen substudy

artículo científico

Risk of stroke in chronic heart failure patients with preserved ejection fraction, but without atrial fibrillation: analysis of the CHARM-Preserved and I-Preserve trials

artículo científico publicado en 2017

Sex differences in clinical characteristics and outcomes in elderly patients with heart failure and preserved ejection fraction: the Irbesartan in Heart Failure with Preserved Ejection Fraction (I-PRESERVE) trial

artículo científico publicado en 2012

Technology-Enabled Remote Monitoring and Self-Management - Vision for Patient Empowerment Following Cardiac and Vascular Surgery: User Testing and Randomized Controlled Trial Protocol

artículo científico publicado en 2016

The Hospitalization Burden and Post-Hospitalization Mortality Risk in Heart Failure With Preserved Ejection Fraction: Results From the I-PRESERVE Trial (Irbesartan in Heart Failure and Preserved Ejection Fraction).

artículo científico publicado en 2015

The irbesartan in heart failure with preserved systolic function (I-PRESERVE) trial: rationale and design

artículo científico publicado en 2005

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda